Couverture de Cross Everything

Cross Everything

Aperçu
Offre à durée limitée

3 mois d'Audible Standard gratuits

3 mois pour 0,00 €/mois, puis 5,99 €/mois. Possibilité de résilier chaque mois.
Essayez pour 0,00 €/mois
L'offre prend fin le 15 Juillet 2026 à 23 h 59.
Plus d'options d'achat

Cross Everything

De : Henry Scowcroft
Lu par : Finlay Robertson
Essayez pour 0,00 €/mois

3 mois pour 0,99 €/mois, puis 5,99 €/mois. Possibilité de résilier chaque mois. Offre valable jusqu'au 15 juillet 2026 à 23 h 59.

Acheter pour 17,99 €

Acheter pour 17,99 €

A heart-wrenching, fascinating and deeply moving take on a disease that half of us will experience at some point in our lives. 

When Henry Scowcroft's partner, Zarah, was diagnosed with stage-four bladder cancer in 2016, their world fell apart. An award-winning science writer for Cancer Research UK, Henry had spent 14 years at the coal-face of cancer research, but now the disease had infiltrated his personal life too. In Cross Everything - his first book - Henry uses this unique perspective to tell the story of Zarah's illness, how he tried in vain to use everything he'd learnt in his professional career to try to save her, and in doing so, how he realised that even a career writing about cancer daily isn't enough preparation for what comes next. 

Along the way, Cross Everything brings the listener up to speed with the latest understanding of cancer - a complex disease with a Darwinian capacity to outsmart its host. 

©2021 Henry Scowcroft (P)2020 W F Howes
Développement personnel Maladie et pathologies physiques Médecine Médecine et secteur des soins de santé Perte et deuil Professionnels et universitaires Relations
adbl_web_anon_alc_button_suppression_c

Commentaires

"A moving, compelling and vital book, that sheds much needed light on the very latest understanding of cancer." (Siddhartha Mukherjee, author of The Emperor of All Maladies)

"Sensitive and informed. Essential for anyone supporting a loved one through cancer." (Deborah James, writer and broadcaster)

Aucun commentaire pour le moment